Filing Details

Accession Number:
0001103021-21-000118
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-11-19 17:20:35
Reporting Period:
2021-11-18
Accepted Time:
2021-11-19 17:20:35
Original Submission Date:
2021-11-19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301715 A Mark Sirgo C/O Biodelivery Sciences Intl, Inc.,
4131 Parklake Avenue, Suite 225
Raleigh NC 27612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-18 10,000 $3.04 1,140,595 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This Form 4/A is being filed to amend the Form 4 filed on November 19, 2021 (the "Original Form 4"). The Original Form 4 incorrectly used transaction code "S," instead of transaction code "P."